Skip to main content
Fig. 2 | BMC Complementary and Alternative Medicine

Fig. 2

From: Chemopreventive and immunomodulatory effects of Murraya koenigii aqueous extract on 4T1 breast cancer cell-challenged mice

Fig. 2

Histological study: Histological emergence of the 4T1 tumor from LR and HR groups. Boxes indicate cells under mitotic division. Black bars signify 200 μm (magnification 40x). The differences between the control or treated group and untreated group were determined by one-way ANOVA (for low risk groups while #for high risk groups; p < 0.05). Normal: normal healthy mice; LR untreated: untreated low risk mice inoculated with 1 × 1044T1 cell/mice; LR MK 50 mg/kg: low risk mice treated with 50 mg/kg of MK extract for 30 days before inoculated with 1 × 104 4T1 cell/mice; LR MK 200 mg/kg: low risk mice treated with 200 mg/kg of MK extract for 30 days before inoculated with 1 × 1044T1 cell/mice; HR untreated: untreated high risk mice inoculated with 1 × 1064T1 cell/mice; HR MK 50 mg/kg: high risk mice treated with 50 mg/kg of MK extract for 30 days before inoculated with 1 × 1064T1 cell/mice; HR MK 200 mg/kg: high risk mice treated with 200 mg/kg of MK extract for 30 days before inoculated with 1 × 1064T1 cell/mice inoculated mice

Back to article page